{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T11:40:56Z","timestamp":1793014856696,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T00:00:00Z","timestamp":1756771200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Sichuan scientific research project plan in 2021","award":["S21057"],"award-info":[{"award-number":["S21057"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-025-14818-1","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T08:05:28Z","timestamp":1756800328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["In-depth evaluation of XPR1 as a new prognostic indicator for endometrial cancer"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiu","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rouzi","family":"Nuermanguli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,2]]},"reference":[{"key":"14818_CR1","doi-asserted-by":"crossref","unstructured":"Mabuchi S, Sasano T. Myeloid-Derived Suppressor Cells as Therapeutic Targets in Uterine Cervical and Endometrial Cancers. Cells. 2021;10(5).","DOI":"10.3390\/cells10051073"},{"key":"14818_CR2","doi-asserted-by":"crossref","unstructured":"Javadian P, Nezhat F. Endometrial Carcinoma and its Precursors. Adv Exp Med Biol. 1242:59\u201372.","DOI":"10.1007\/978-3-030-38474-6_4"},{"issue":"1","key":"14818_CR3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004049","volume":"4","author":"KF Brookfield","year":"2009","unstructured":"Brookfield KF, Cheung MC, Yang R, Byrne MM, Koniaris LG. Will patients benefit from regionalization of gynecologic cancer care? PLoS ONE. 2009;4(1): e4049.","journal-title":"PLoS ONE"},{"issue":"6","key":"14818_CR4","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/S0929-6646(09)60098-X","volume":"108","author":"YL Chen","year":"2009","unstructured":"Chen YL, Cheng WF, Lin MC, Huang CY, Hsieh CY, Chen CA. Concurrent endometrial carcinoma in patients with a curettage diagnosis of endometrial hyperplasia. J Formos Med Assoc. 2009;108(6):502\u20137.","journal-title":"J Formos Med Assoc"},{"issue":"5","key":"14818_CR5","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.prp.2019.02.007","volume":"215","author":"S Guo","year":"2019","unstructured":"Guo S, Yang J, Wu M, Xiao G. Clinical value screening, prognostic significance and key pathway identification of miR-204-5p in endometrial carcinoma: A study based on the Cancer Genome Atlas (TCGA), and bioinformatics analysis. Pathol Res Pract. 2019;215(5):1003\u201311.","journal-title":"Pathol Res Pract"},{"issue":"6","key":"14818_CR6","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/cam4.139","volume":"2","author":"K Hasumi","year":"2013","unstructured":"Hasumi K, Sugiyama Y, Sakamoto K, Akiyama F. Small endometrial carcinoma 10 mm or less in diameter: clinicopathologic and histogenetic study of 131 cases for early detection and treatment. Cancer Med. 2013;2(6):872\u201380.","journal-title":"Cancer Med"},{"issue":"2","key":"14818_CR7","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/PGP.0000000000000866","volume":"42","author":"N Banet","year":"2023","unstructured":"Banet N, Masnick M, Quddus MR. Evaluation of Saccharomyces cerevisiae -like 1 (SEC14L1) in Gynecologic Malignancies Shows Overexpression in Endometrial Serous Carcinoma. Int J Gynecol Pathol. 2023;42(2):136\u201342.","journal-title":"Int J Gynecol Pathol"},{"issue":"7","key":"14818_CR8","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1097\/IGC.0000000000000183","volume":"24","author":"S Bashir","year":"2014","unstructured":"Bashir S, Jiang G, Joshi A, et al. Molecular alterations of PIK3CA in uterine carcinosarcoma, clear cell, and serous tumors. Int J Gynecol Cancer. 2014;24(7):1262\u20137.","journal-title":"Int J Gynecol Cancer"},{"issue":"19","key":"14818_CR9","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1093\/jnci\/djs345","volume":"104","author":"E Kuhn","year":"2012","unstructured":"Kuhn E, Wu RC, Guan B, et al. Identification of molecular pathway aberrations in uterine serous carcinoma by genome-wide analyses. J Natl Cancer Inst. 2012;104(19):1503\u201313.","journal-title":"J Natl Cancer Inst"},{"issue":"7447","key":"14818_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nature12113","volume":"497","author":"C Kandoth","year":"2013","unstructured":"Kandoth C, Schultz N, et al. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67\u201373.","journal-title":"Nature"},{"issue":"9","key":"14818_CR11","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1158\/1078-0432.CCR-20-4436","volume":"27","author":"A Momeni-Boroujeni","year":"2021","unstructured":"Momeni-Boroujeni A, Dahoud W, Vanderbilt CM, et al. Clinicopathologic and Genomic Analysis of TP53-Mutated Endometrial Carcinomas. Clin Cancer Res. 2021;27(9):2613\u201323.","journal-title":"Clin Cancer Res"},{"key":"14818_CR12","doi-asserted-by":"crossref","unstructured":"Sun C, Guan H, Li J, Gu Y. RBM15-mediated m6A modification of XPR1 promotes the malignant progression of lung adenocarcinoma. Naunyn Schmiedebergs Arch Pharmacol. Published online Feb 10,2025.","DOI":"10.1007\/s00210-025-03849-x"},{"key":"14818_CR13","doi-asserted-by":"crossref","unstructured":"Hu Y, Bai J, Zhou D, et al. The miR-4732\u20135p\/XPR1 axis suppresses the invasion, metastasis, and epithelial-mesenchymal transition of lung adenocarcinoma\u00a0via\u00a0the PI3K\/Akt\/GSK3\u03b2\/Snail pathway. Mol Omics. 2022;18(5):417\u2013429. Published 2022 Jun 13.","DOI":"10.1039\/D1MO00245G"},{"key":"14818_CR14","doi-asserted-by":"crossref","unstructured":"Jia M, Liang J, Li Z, et al. Screening tumor stage-specific candidate neoantigens in thyroid adenocarcinoma using integrated exome and transcriptome sequencing. Front Immunol. 14:1187160. Published 2023 None.","DOI":"10.3389\/fimmu.2023.1187160"},{"key":"14818_CR15","doi-asserted-by":"crossref","unstructured":"Ye Y, Li H, Bian J, Wang L, Wang Y, Huang H. Exploring Prognosis-Associated Biomarkers of Estrogen-Independent Uterine Corpus Endometrial Carcinoma by Bioinformatics Analysis. Int J Gen Med. 14:9067\u20139081.","DOI":"10.2147\/IJGM.S341345"},{"issue":"1","key":"14818_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/s44178-022-00010-z","volume":"1","author":"W Gao","year":"2022","unstructured":"Gao W, Wang J, Yin S, Geng C, Xu B. An appropriate treatment interval does not affect the prognosis of patients with breast Cancer. Holist Integr Oncol. 2022;1(1):8.","journal-title":"Holist Integr Oncol"},{"issue":"4","key":"14818_CR17","doi-asserted-by":"publisher","first-page":"290","DOI":"10.2174\/1566523220666201229155833","volume":"21","author":"W Wu","year":"2021","unstructured":"Wu W, Zhang Y, Li X, Wang X, Yuan Y. miR-375 Inhibits the Proliferation, Migration and Invasion of Esophageal Squamous Cell Carcinoma by Targeting XPR1. Curr Gene Ther. 2021;21(4):290\u20138.","journal-title":"Curr Gene Ther"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14818-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-14818-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-14818-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T04:13:21Z","timestamp":1757477601000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-14818-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14818"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-14818-1","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"14 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not necessary for this study as it did not involve human or animal subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1411"}}